Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial
The formulation does not contain therapeutic agents and is designed exclusively for reconstituting, diluting, or dissolving compatible compounds prior to research use
Current View Current View Enter the password to open this PDF file: File name: - File size: - Title: - Author: - Subject: - Keywords: - Creation Date: - Modification Date: - Creator: - PDF Producer: - PDF Version: - Page Count: - Page Size: - Fast Web View: - Preparing document for printing 0%
Sources and full results Most relevant research papers on this topic DOI DOI DOI DOI DOI DOI
US$ 20.52
US$ 20.78
US$ 20.70
US$ 21.37
US$ 21.24
US$ 25.75
